FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Medical Advisory Committee

From breakthroughs in the lab to real-world progress—accelerating research that delivers results for families today.

Find MDA
in your Community